SEC Filings

Filing date	Form	Description	View
11/18/22	SC TO-I/A	Amendment to a previously filed SC TO-I	View HTML 0001104659-22-120046.pdf 0001104659-22-120046.rtf 0001104659-22-120046.xls
11/17/22	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-22-011523.pdf 0001415889-22-011523.rtf 0001415889-22-011523.xls
11/14/22	SC TO-I/A	Amendment to a previously filed SC TO-I	View HTML 0001104659-22-117539.pdf 0001104659-22-117539.rtf
11/14/22	8-K/A	Amendment to a previously filed 8-K	View HTML 0001104659-22-117504.pdf 0001104659-22-117504.rtf 0001104659-22-117504.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
11/09/22	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0001558370-22-017048.pdf 0001558370-22-017048.rtf 0001558370-22-017048.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
11/09/22	SC TO-I/A	Amendment to a previously filed SC TO-I	View HTML 0001104659-22-116471.pdf 0001104659-22-116471.rtf 0001104659-22-116471.xls
11/07/22	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-22-115424.pdf 0001104659-22-115424.rtf 0001104659-22-115424.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
11/07/22	SC TO-I/A	Amendment to a previously filed SC TO-I	View HTML 0001104659-22-115440.pdf 0001104659-22-115440.rtf 0001104659-22-115440.xls
11/03/22	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-22-114114.pdf 0001104659-22-114114.rtf 0001104659-22-114114.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
10/21/22	3	Initial filing by director officer or owner of more than ten percent	View HTML 0001877589-22-000006.pdf 0001877589-22-000006.rtf 0001877589-22-000006.xls

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.